Read more
17:48 ยท 23 April 2026

BREAKING: US PMIs beat estimates ๐Ÿ“ˆ Stocks back in the green

14:45 GMT - United States - PMI report:

  • S&P Composite PMI Flash Actual 52 (Forecast 50.6, Previous 50.3)

  • S&P Manufacturing PMI Flash Actual 54 (Forecast 52.5, Previous 52.3)

  • S&P Services PMI Flash Actual 51.3 (Forecast 50.6, Previous 49.8)

 

April’s preliminary US PMIs supprised on the upside, with manufacturing, services and the composite index all beating expectations. While this signals robust economic momentum despite geopolitical stress, the underlying details are more nuanced: employment edged up to 50.2, but new orders actually softened slightly to 50.9. The real sting lies in the pricing data, where input prices jumped to 62.6 and output prices hit 59.9—their highest level since July 2022.

Although these inflationary signals make the report less "market-friendly" than the headlines imply, US stocks ticked slightly up, shaking off early pressure from Brent crude prices crossing the 100 USD mark. S&P 500 futures reversed early losses and climbed higher immediately following the report, curently settling at yesterday's close.

 

Source: xStation5

24 April 2026, 16:45

Market Wrap: Indices try to recover on US-Iran negotiations hopes ๐Ÿ‡ช๐Ÿ‡บ SAP surges 6% after earnings ๐Ÿ“ˆ

24 April 2026, 13:06

Chart of the day: US100 (24.04.2026)

24 April 2026, 11:27

Economic calendar: US UoM data in the spotlight (24.04.2026)

24 April 2026, 10:23

UK retail sales surprised the market in a positive way๐Ÿ’ก

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.